Thrombosis and Hemostasis Research
Thrombosis is a crucial hemostatic process for maintaining blood volume (hemostasis) following injury, yet aberrant thrombosis can trigger pathological conditions including myocardial infarction and stroke. Therefore the initiation of thrombosis is tightly controlled under physiological conditions.
Thrombosis and Hemostasis Research Products Targets
- PI 3-kinase (22)
- Cell Adhesion Molecule (21)
- Others (7)
- Cyclooxygenase (24)
- PPARγ (16)
- PPARδ (5)
- PPARα (7)
- NK2 Receptor (7)
- NK1 Receptor (15)
- NK3 Receptor (5)
- Chemokine CXC Receptor (9)
- Chemokine CC Receptor (13)
- NO donors and precursors (9)
- nNOS (5)
- iNOS (11)
- eNOS (1)
- Purinergic (P2Y) Receptor (31)
- Protease-Activated Receptor (23)
- Phospholipase (16)
- Prostanoid Receptor (24)
- Phosphodiesterase (34)
Products for Thrombosis and Hemostasis Research - Page 18
- Cat.No. Product Name Information/Activity
-
BCC5879
MRS 2365
436847-09-5
-
BCC7514
MRS 2690
15039-58-4
-
BCC7386
MRS 2693 trisodium salt
1448858-83-0
-
BCC7800
MRS 2768 tetrasodium salt
1047980-83-5
-
BCC6133
MRS 2957 triethylammonium salt
1228271-30-4
-
BCC6134
MRS 4062 triethylammonium salt
1309871-50-8
-
BCC7804
NF 546
NF546 is a selective non-nucleotide P2Y11 agonist with a pEC50 of 6.27. NF546 stimulates release of interleukin-8 from human monocyte-derived dendritic cells.
-
BCC6153
5-OMe-UDP trisodium salt
Potent P2Y<sub>6</sub> agonist
-
BCC7459
PSB 0474
917567-60-3
-
BCC7625
2-ThioUTP tetrasodium salt
1343364-70-4
